BioNexus Gene Lab Other Current Liabilities

BioNexus Gene Lab posts a other current liabilities of $740K as of June 2026. That compares with $320K in the prior-year period — up 129.3% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, BioNexus Gene Lab's other current liabilities was $320K. The latest reading is $740K — a 129.3% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Other Current Liabilities is one piece of BioNexus Gene Lab's financial statement story. At $740K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BGLC's other current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; BioNexus Gene Lab's other metric pages and overview cover the third.